George Clinical, a leading Asia-Pacific CRO, have now achieved Medidata Rave® accreditation. Adding this platform to George Clinical’s robust stable of electronic data collection systems will allow George Clinical to further enhance the clinical data collection process for a broader range of customers.
Headquartered in Sydney with 260 staff operating in 11 countries. George Clinical provides a full range of trial management services to pharmaceutical, medical device and biotech customers, for both registration and post marketing trials. As clinical trial costs and complexities continue to escalate, George Clinical provides tailored solutions to accessing patient populations, and ensuring that clinical trials have an impact for clinicians and patients.
“George Clinical welcomes the addition of Medidata Rave, Medidata’s industry leading electronic data capture, management and reporting system, to our stable of data platforms,” Dr Marisa Petersen, Chief Executive Officer of George Clinical said. “We appreciate the significant value-add Medidata Rave will deliver to many of our customers. George Clinical already provides our global customer base with unparalleled access to China, India and the broader Asia-Pacific region. Now, with Medidata Rave as an important component of our full-range of trial management services, our company will continue to lead the way in the collection of data to the highest scientific and clinical trial standards.”
About George Clinical
George Clinical is a leading clinical research organization in Asia, with 260 staff operating in 11 countries. George Clinical provides a full range of trial management services to pharmaceutical, medical device and biotech customers, for both registration and post-marketing trials. George Clinical’s unique operational model allows them to leverage well-established relationships with thought leaders and physicians across Australia and Asia, ensuring access to the best clinical trial sites and patients. As clinical trial costs and complexity escalate, George Clinical provide customers with innovative ways to access patient populations; ensuring that their clinical trials have an impact for clinicians and patients.
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. We are committed to advancing the competitive and scientific goals of our life sciences customers worldwide: more than 700 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations. Our industry-leading technology platform, the Medidata Clinical Cloud®, is the primary technology solution powering clinical trials for 17 of the world’s top 25 global pharmaceutical companies, bringing new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting.